NASCO的动态

查看NASCO的组织主页

16,191 位关注者

NASCO convened healthcare thought leaders to discuss the opportunities and risks of using artificial intelligence (AI) and generative AI (genAI). Daniel Andrew Carnegie, MD, MPH, MBA, Chief Resident, UNC Preventive Medicine Karl Hightower, C-Suite Technology and Transformation Executive, Catalyst at Wellstar Christopher Kunney, a senior-level health information technology executive and strategist, Managing Partner at IOTECH Consulting David Weeks, NASCO’s Chief Digital and Technology Officer To learn more, read a new article by NASCO’s David Weeks #healthcareAI #AI #genAI

Christopher Kunney, FHIMSS, eFACHDM, MSMOT

Brain Tumor Survivor, ACHDM & HIMSS Fellow & Ambassador, ForbesBLK, Partner - IOTECH, Morehouse School of Medicine Industry & Faculty-Dignity Health Global Education, HIMSS Changemaker, Podcast Host, CHIME Alumni

7 个月

Thank you for inviting me to participate in the panel discussion. I definitely enjoyed the lively discussion on the possibilities and pitfall associated with the deployment of AI in both the payor and provider environments.

Elise Mihranian

Communications Expert | Connector of People & Ideas | Change Agent | Storyteller

7 个月

Great insights!

回复
Andrea Durkin

Content Writer & Strategist * Healthcare Marketer & Freelance Writer * Product Marketing

7 个月

Sounds like an insightful and practical discussion about healthcare AI.

回复
查看更多评论

要查看或添加评论,请登录